Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer

Completed · Phase 2

Conditions studied: Colorectal Cancer

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of oxaliplatin in treating patients who have recurrent metastatic colorectal cancer.

Key facts

Study ID

NCT00017082

Run by

Prologue Research International

Starts

2001-04-01

Expected to finish

2010-12-01

Last updated by the study team

2013-06-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Washington Cancer Institute — Washington D.C., District of Columbia, United States
• Comprehensive Cancer Care Specialists of Boca Raton — Boca Raton, Florida, United States
• Kentuckiana Cancer Institute — Louisville, Kentucky, United States
• University of Nebraska Medical Center — Omaha, Nebraska, United States
• Veterans Affairs Medical Center - Albany — Albany, New York, United States
• Southeastern Medical Oncology Center — Goldsboro, North Carolina, United States
• Raleigh Hematology/Oncology Associates - Wake Practice — Raleigh, North Carolina, United States
• Pinnacle Health Hospitals — Harrisburg, Pennsylvania, United States
• University of Pennsylvania Cancer Center — Philadelphia, Pennsylvania, United States
• Memphis Cancer Center — Memphis, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.